Artificial intelligence (AI) is a technology that simulates human intelligence in machines, enabling them to think and behave such as humans. AI is known for its ability to perform tasks quickly and with relatively few errors.
The primary technologies employed in AI for drug discovery are deep learning and machine learning. Deep learning is a technique within machine learning and AI that emulates how humans acquire knowledge. Data science, encompassing statistics and predictive modeling, integrates deep learning as a crucial component. Drug discovery involves various types of drugs, including small molecules and large molecules, and encompasses different therapeutic approaches such as c and others. The implementation of AI in drug discovery is seen across various end-users, including pharmaceutical companies, biopharmaceutical companies, academic and research institutes, among others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The artificial intelligence (AI) in drug discovery market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI) in drug discovery market statistics, including artificial intelligence (AI) in drug discovery industry global market size, regional shares, competitors with a artificial intelligence (AI) in drug discovery market share, detailed artificial intelligence (AI) in drug discovery market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI) in drug discovery industry. This artificial intelligence (AI) in drug discovery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The artificial intelligence (AI) in drug discovery market size has grown exponentially in recent years. It will grow from $1.78 billion in 2024 to $2.33 billion in 2025 at a compound annual growth rate (CAGR) of 30.5%. The growth in the historic period can be attributed to growth in emerging markets, the rising prevalence of chronic diseases, the increased adoption of artificial intelligence (AI) for cost-efficient drug discovery, and the increasing strict quality regulations for drug manufacturers.
The artificial intelligence (AI) in drug discovery market size is expected to see exponential growth in the next few years. It will grow to $5.89 billion in 2029 at a compound annual growth rate (CAGR) of 26.1%. The growth in the forecast period can be attributed to government support, increasing healthcare expenditure, and rising adoption of cloud-based applications and services. Major trends in the forecast period include the integration of multi-omics data, the use of AI in target selection, the use of AI in drug screening, the introduction of AI innovation labs, and increasing investments in partnerships and collaborations.
The forecast of 26.1% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. pharmaceutical Research and Development (R&D) by increasing costs for Artificial intelligence(AI)-based molecular modeling software and predictive Absorption, Distribution, Metabolism, Excretion, and Toxicity(ADMET) platforms imported from the UK and Singapore, potentially delaying new drug development and raising research costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The escalating demand for personalized medicine stands as a driving force behind the burgeoning growth of the artificial intelligence (AI) in drug discovery market. Personalized medicine, which tailors treatments based on individual genetic or protein knowledge, has surged in importance. AI's pivotal role spans various phases of clinical development and in the creation of new personalized health solutions. It significantly aids in identifying suitable intervention targets and evaluating their effectiveness. Notably, the US FDA's approval of 12 personalized medicines in 2022, representing about 34% of newly endorsed therapeutic molecular entities, attests to this surge. The heightened demand for personalized medicine is thereby fueling the expansion of the AI in drug discovery market.
The increasing demand for reducing the overall time required for the drug discovery process is a significant driver behind the growth of artificial intelligence (AI) in the drug discovery market. Traditionally, it takes three to five years to identify and optimize molecules using animal models before they are evaluated in humans. In contrast, AI-based start-ups can identify and design new drugs in just a few days or months. In June 2024, Benevolent AI, a UK-based leader in applying advanced AI to accelerate biopharma drug discovery, announced a collaboration with AstraZeneca, a UK-based pharmaceutical and biotechnology company. Their partnership aims to leverage AI to enhance target discovery for chronic kidney disease and idiopathic pulmonary fibrosis. Recently, they reported advancements in developing additional targets, showcasing the effectiveness of AI-driven approaches in drug development.
Major players in the AI drug delivery sector are forging strategic collaborations to delve deeper into drug discovery leveraging AI, a move that's elevating their position within the artificial intelligence in drug discovery market. Take Atomwise, a US-based AI systems company, which partnered with Sanofi in August 2022. This collaboration aims to identify and explore up to five pharmacological targets utilizing Atomwise's AI-driven AtomNet technology. To facilitate the discovery of lead compounds for Sanofi's exclusive targets, Atomwise received an initial payment of $20 million from Sanofi, a prominent French pharmaceutical and healthcare company.
Major corporations are making significant investments in entities operating within the artificial intelligence (AI) in drug discovery domain. These investments aim to facilitate the identification and design of novel therapies, ultimately offering these models to other pharmaceutical firms. Given that drug discovery is both capital-intensive and time-consuming, such strategic investments provide vital funding for research and development of new drugs. This funding often serves as a catalyst for these companies to propel their drug discovery initiatives, expediting the introduction of new treatments into the market. For instance, in July 2023, Nvidia, a leading US-based software company, made a $50 million investment in Recursion Pharmaceuticals, a US-based biotech firm harnessing artificial intelligence (AI) for drug discovery. This infusion of capital is poised to empower Recursion in accelerating the development of its AI foundation models for biology and chemistry by leveraging Nvidia's cloud services.
In December 2022, Tecnotree Corporation, a Finnish telecommunications company, successfully acquired CognitiveScale for a total investment of $6 million. This strategic acquisition is expected to significantly boost Tecnotree's AI capabilities, presenting potential opportunities for the pharmaceutical industry. Leveraging these enhanced AI capabilities, Tecnotree aims to explore and develop innovative AI-powered solutions for drug discovery and advancement. CognitiveScale, a reputable AI software company based in the United States, will contribute to Tecnotree's strategic vision in this evolving landscape.
Major companies operating in the artificial intelligence (AI) in drug discovery market include IBM Corporation, Microsoft Corporation, NVIDIA Corporation, Exscientia, Alphabet, Insilico Medicine, Owkin Inc, Xtalpi Inc, Cloud Pharmaceuticals, Shanghai PharmaceuticS, Standigm, Indegene, Intuition Systems, Innoplexus, Takeda Pharmaceutical Company Ltd., RxPrism, Otsuka Pharmaceutical Co. Ltd., China National Pharmaceutical Group Co., Ltd., Jiangsu Hengrui Medicine Co., Ltd, Cipla Limited, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Sun Pharma, Tricog Health Services Pvt. Ltd., Alliance Pharm Pte Ltd., CytoReason, IIPharma, StoneWise, Adagene, GT Apeiron Therapeutics, Xbiome, Accutar Biotech, DeepMind, Renalytix AI, Iktos, Ipsen Pharma, Galderma S.A., BenevolentAI, Deepflare, Novartis, Gero, Ardigen, Botkin, Care Mentor AI, Diagnocat, GNS Healthcare, Merck & Co., Apotex, Pfizer, Gilead Sciences, Roche, Bayer, AbbVie Inc., GlaxoSmithKline, AstraZeneca, Amgen, Sanofi Pasteur, Abbott Laboratories, Teva Canada, Accord Healthcare Inc, Acerus Pharmaceuticals Corporation, AA Pharma Inc, Sanfer, Siegfried Rhein, Atomwise, Inc., Bioage, NuMedii, Envisagenics, Aria Pharmaceuticals, Verge Genomics, Berg LLC, Deep Genomics, Cyclica, IQVIA, Quris, GE Healthcare, Avanade, Group42 Holding Ltd, Ilara Health, Adcock Ingram, Johnson & Johnson, Eurolab, Ranbaxy (SA) (Pty) Ltd, Aspen, Rology, hearX Group, DilenyTech
North America was the largest region in the artificial intelligence (AI) in drug discovery market in 2024. Western Europe was the second largest region in the global artificial intelligence (AI) in drug discovery market share. The regions covered in the artificial intelligence (AI) in drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the artificial intelligence (AI) in drug discovery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain
The artificial intelligence (AI) in drug discovery market includes revenues earned by entities by offering AI for drug discovery. Artificial Intelligence (AI) for drug discovery is a technology that uses a simulation of the human intelligence process by machines to tackle complex problems in the drug discovery process. It helps to find new molecules to identify drug targets and develop personalized medicines in the pharmaceutical industry. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Artificial Intelligence (AI) In Drug Discovery Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on artificial intelligence (ai) in drug discovery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for artificial intelligence (ai) in drug discovery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence (ai) in drug discovery market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Technology: Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning
- 2) By Drug Type: Small Molecules, Large Molecules
- 3) By Therapeutic Type: Metabolic Disease, Cardiovascular Disease, Oncology, Neurodegenerative Diseases, Anti-Infective Diseases, Respiratory Diseases, Other Therapeutics
- 4) By End User: Pharmaceutical Companies, Biopharmaceutical Companies, Academic And Research Institutes, Other End-Users
- Subsegments:
- 1) By Context-Aware Processing: Contextual Data Integration; Predictive Modeling; Adaptive Learning Systems
- 2) By Natural Language Processing (NLP): Text Mining And Analysis; Sentiment Analysis; Drug Interaction Extraction; Clinical Trial Data Analysis
- 3) By Querying Method: Semantic Search; Knowledge Graphs; Structured Query Language (SQL) Based Queries
- 4) By Deep Learning: Neural Networks; Convolutional Neural Networks (CNNs); Recurrent Neural Networks (RNNs); Reinforcement Learning Applications
- Companies Mentioned: IBM Corporation; Microsoft Corporation; NVIDIA Corporation; Exscientia; Alphabet; Insilico Medicine; Owkin Inc; Xtalpi Inc; Cloud Pharmaceuticals; Shanghai PharmaceuticS; Standigm; Indegene; Intuition Systems; Innoplexus; Takeda Pharmaceutical Company Ltd.; RxPrism; Otsuka Pharmaceutical Co. Ltd.; China National Pharmaceutical Group Co., Ltd.; Jiangsu Hengrui Medicine Co., Ltd; Cipla Limited; Aurobindo Pharma Limited; Dr. Reddy's Laboratories Ltd.; Sun Pharma; Tricog Health Services Pvt. Ltd.; Alliance Pharm Pte Ltd.; CytoReason; IIPharma; StoneWise; Adagene; GT Apeiron Therapeutics; Xbiome; Accutar Biotech; DeepMind; Renalytix AI; Iktos; Ipsen Pharma; Galderma S.A.; BenevolentAI; Deepflare; Novartis; Gero; Ardigen; Botkin; Care Mentor AI; Diagnocat; GNS Healthcare; Merck & Co.; Apotex; Pfizer; Gilead Sciences; Roche; Bayer; AbbVie Inc.; GlaxoSmithKline; AstraZeneca; Amgen; Sanofi Pasteur; Abbott Laboratories; Teva Canada; Accord Healthcare Inc; Acerus Pharmaceuticals Corporation; AA Pharma Inc; Sanfer; Siegfried Rhein; Atomwise, Inc.; Bioage; NuMedii; Envisagenics; Aria Pharmaceuticals; Verge Genomics; Berg LLC; Deep Genomics; Cyclica; IQVIA; Quris; GE Healthcare; Avanade; Group42 Holding Ltd; Ilara Health; Adcock Ingram; Johnson & Johnson; Eurolab; Ranbaxy (SA) (Pty) Ltd; Aspen; Rology; hearX Group; DilenyTech
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time Series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Artificial Intelligence (AI) In Drug Discovery Market Characteristics
3. Artificial Intelligence (AI) In Drug Discovery Market Trends And Strategies
4. Artificial Intelligence (AI) In Drug Discovery Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Artificial Intelligence (AI) In Drug Discovery Growth Analysis And Strategic Analysis Framework
- 5.1. Global Artificial Intelligence (AI) In Drug Discovery PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Artificial Intelligence (AI) In Drug Discovery Market Growth Rate Analysis
- 5.4. Global Artificial Intelligence (AI) In Drug Discovery Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Artificial Intelligence (AI) In Drug Discovery Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Artificial Intelligence (AI) In Drug Discovery Total Addressable Market (TAM)
6. Artificial Intelligence (AI) In Drug Discovery Market Segmentation
- 6.1. Global Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Context-Aware Processing
- Natural Language Processing
- Querying Method
- Deep Learning
- 6.2. Global Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Small Molecules
- Large Molecules
- 6.3. Global Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Metabolic Disease
- Cardiovascular Disease
- Oncology
- Neurodegenerative Diseases
- Anti-Infective Diseases
- Respiratory Diseases
- Other Therapeutics
- 6.4. Global Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Pharmaceutical Companies
- Biopharmaceutical Companies
- Academic And Research Institutes
- Other End-Users
- 6.5. Global Artificial Intelligence (AI) In Drug Discovery Market, Sub-Segmentation Of Context-Aware Processing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Contextual Data Integration
- Predictive Modeling
- Adaptive Learning Systems
- 6.6. Global Artificial Intelligence (AI) In Drug Discovery Market, Sub-Segmentation Of Natural Language Processing (NLP), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Text Mining And Analysis
- Sentiment Analysis
- Drug Interaction Extraction
- Clinical Trial Data Analysis
- 6.7. Global Artificial Intelligence (AI) In Drug Discovery Market, Sub-Segmentation Of Querying Method, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Semantic Search
- Knowledge Graphs
- Structured Query Language (SQL) Based Queries
- 6.8. Global Artificial Intelligence (AI) In Drug Discovery Market, Sub-Segmentation Of Deep Learning, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Neural Networks
- Convolutional Neural Networks (CNNs)
- Recurrent Neural Networks (RNNs)
- Reinforcement Learning Applications
7. Artificial Intelligence (AI) In Drug Discovery Market Regional And Country Analysis
- 7.1. Global Artificial Intelligence (AI) In Drug Discovery Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Artificial Intelligence (AI) In Drug Discovery Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Artificial Intelligence (AI) In Drug Discovery Market
- 8.1. Asia-Pacific Artificial Intelligence (AI) In Drug Discovery Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Artificial Intelligence (AI) In Drug Discovery Market
- 9.1. China Artificial Intelligence (AI) In Drug Discovery Market Overview
- 9.2. China Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Artificial Intelligence (AI) In Drug Discovery Market
- 10.1. India Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Artificial Intelligence (AI) In Drug Discovery Market
- 11.1. Japan Artificial Intelligence (AI) In Drug Discovery Market Overview
- 11.2. Japan Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Artificial Intelligence (AI) In Drug Discovery Market
- 12.1. Australia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Artificial Intelligence (AI) In Drug Discovery Market
- 13.1. Indonesia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Artificial Intelligence (AI) In Drug Discovery Market
- 14.1. South Korea Artificial Intelligence (AI) In Drug Discovery Market Overview
- 14.2. South Korea Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Artificial Intelligence (AI) In Drug Discovery Market
- 15.1. Western Europe Artificial Intelligence (AI) In Drug Discovery Market Overview
- 15.2. Western Europe Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Artificial Intelligence (AI) In Drug Discovery Market
- 16.1. UK Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Artificial Intelligence (AI) In Drug Discovery Market
- 17.1. Germany Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Artificial Intelligence (AI) In Drug Discovery Market
- 18.1. France Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Artificial Intelligence (AI) In Drug Discovery Market
- 19.1. Italy Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Artificial Intelligence (AI) In Drug Discovery Market
- 20.1. Spain Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Artificial Intelligence (AI) In Drug Discovery Market
- 21.1. Eastern Europe Artificial Intelligence (AI) In Drug Discovery Market Overview
- 21.2. Eastern Europe Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Artificial Intelligence (AI) In Drug Discovery Market
- 22.1. Russia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Artificial Intelligence (AI) In Drug Discovery Market
- 23.1. North America Artificial Intelligence (AI) In Drug Discovery Market Overview
- 23.2. North America Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Artificial Intelligence (AI) In Drug Discovery Market
- 24.1. USA Artificial Intelligence (AI) In Drug Discovery Market Overview
- 24.2. USA Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Artificial Intelligence (AI) In Drug Discovery Market
- 25.1. Canada Artificial Intelligence (AI) In Drug Discovery Market Overview
- 25.2. Canada Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Artificial Intelligence (AI) In Drug Discovery Market
- 26.1. South America Artificial Intelligence (AI) In Drug Discovery Market Overview
- 26.2. South America Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Artificial Intelligence (AI) In Drug Discovery Market
- 27.1. Brazil Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Artificial Intelligence (AI) In Drug Discovery Market
- 28.1. Middle East Artificial Intelligence (AI) In Drug Discovery Market Overview
- 28.2. Middle East Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Artificial Intelligence (AI) In Drug Discovery Market
- 29.1. Africa Artificial Intelligence (AI) In Drug Discovery Market Overview
- 29.2. Africa Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Artificial Intelligence (AI) In Drug Discovery Market Competitive Landscape And Company Profiles
- 30.1. Artificial Intelligence (AI) In Drug Discovery Market Competitive Landscape
- 30.2. Artificial Intelligence (AI) In Drug Discovery Market Company Profiles
- 30.2.1. IBM Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. NVIDIA Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Exscientia Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Alphabet Overview, Products and Services, Strategy and Financial Analysis
31. Artificial Intelligence (AI) In Drug Discovery Market Other Major And Innovative Companies
- 31.1. Insilico Medicine
- 31.2. Owkin Inc
- 31.3. Xtalpi Inc
- 31.4. Cloud Pharmaceuticals
- 31.5. Shanghai PharmaceuticS
- 31.6. Standigm
- 31.7. Indegene
- 31.8. Intuition Systems
- 31.9. Innoplexus
- 31.10. Takeda Pharmaceutical Company Ltd.
- 31.11. RxPrism
- 31.12. Otsuka Pharmaceutical Co. Ltd.
- 31.13. China National Pharmaceutical Group Co., Ltd.
- 31.14. Jiangsu Hengrui Medicine Co., Ltd
- 31.15. Cipla Limited
32. Global Artificial Intelligence (AI) In Drug Discovery Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Artificial Intelligence (AI) In Drug Discovery Market
34. Recent Developments In The Artificial Intelligence (AI) In Drug Discovery Market
35. Artificial Intelligence (AI) In Drug Discovery Market High Potential Countries, Segments and Strategies
- 35.1 Artificial Intelligence (AI) In Drug Discovery Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Artificial Intelligence (AI) In Drug Discovery Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Artificial Intelligence (AI) In Drug Discovery Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
